Inato
Matching research sites to the right clinical trial protocols, unlocking site potential worldwide.
Matching research sites to the right clinical trial protocols, unlocking site potential worldwide.
Published Oct 6, 2026
| Starting Price | Sites: reported as no charge (vendor statement). Sponsor pricing not published. | Quote-based (no public rate card located). | Custom quote / demo-based pricing (vendor-provided). |
| Best For | Sponsors focused on structured site matching and expanding community site access; sites seeking access to sponsor trials and AI-assisted pre-screening without paying software fees (vendor-stated). | Sponsors/sites emphasizing patient recruitment operations, pre-qualified referrals, and recruitment analytics. | Sponsors running decentralized/hybrid trials needing eConsent/eCOA/participant apps/televisits and operational tooling. |
| Key Strength | Two-sided network with site and sponsor workflows; vendor-published verification of Enrollment Plans; AI-assisted pre-screening workflows supporting PDF upload. | Recruitment-focused offerings and referral pipeline capabilities. | Broad decentralized trial feature set and enterprise trial execution tooling. |
| Key Weakness | Limited transparent third-party reviews; sponsor pricing opacity; community reports of limited therapeutic area coverage and declines after site effort. | Primarily recruitment-focused rather than a full site-selection marketplace. | Potentially longer deployments and variable cost depending on study complexity. |
—
Inato focuses on sponsor–site matching and feasibility/enrollment planning combined with patient pre-screening, while competitors may focus on patient recruitment operations (Trialbee) or broader decentralized trial execution tooling (Medable). Depending on the organization’s primary bottleneck, different vendors may be more suitable:
Where competitors may clearly be preferable:
Market adoption indicators in the reviewed materials are limited to vendor-published metrics and trade reporting that identify Inato as a venture-backed participant in the site selection/matching category.